Hedge Fund - Wynnefield Capital
Lifecore Biomedical Inc. (LFCR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $38,472,306 | 21.63% | 4,703,216 | $7.40 |
| 2 | 2025 - Q3 (2025-09-30) | $34,615,669 | 20.8% | 4,703,216 | $7.57 |
| 3 | 2025 - Q2 (2025-06-30) | $38,190,113 | 22.53% | 4,703,216 | $6.74 |
| 4 | 2025 - Q1 (2025-03-31) | $33,110,640 | 20.95% | 4,703,216 | $6.21 |
| 5 | 2024 - Q4 (2024-12-31) | $34,944,894 | 15.92% | 4,703,216 | $6.39 |
| 6 | 2024 - Q3 (2024-09-30) | $24,250,566 | 10.79% | 4,918,979 | $5.22 |
| 7 | 2024 - Q2 (2024-06-30) | $25,234,362 | 11.34% | 4,918,979 | $5.92 |
| 8 | 2024 - Q1 (2024-03-31) | $26,144,024 | 10.38% | 4,923,545 | $7.15 |
| 9 | 2023 - Q4 (2023-12-31) | $30,476,744 | 11.78% | 4,923,545 | $6.94 |
| 10 | 2023 - Q3 (2023-09-30) | $37,148,147 | 17.04% | 4,923,545 | $9.14 |
| 11 | 2023 - Q2 (2023-06-30) | $47,610,680 | 23.8% | 4,923,545 | $6.11 |
| 12 | 2023 - Q1 (2023-03-31) | $18,586,382 | 12.03% | 4,923,545 | $5.57 |
| 13 | 2022 - Q4 (2022-12-31) | $28,917,065 | 16.63% | 4,462,510 | $8.24 |
| 14 | 2022 - Q3 (2022-09-30) | $31,411,000 | 16.56% | 3,533,287 | $10.17 |
| 15 | 2022 - Q2 (2022-06-30) | $35,227,000 | 17.8% | 3,533,287 | $9.90 |
| 16 | 2022 - Q1 (2022-03-31) | $40,915,000 | 15.61% | 3,533,287 | $11.14 |
| 17 | 2021 - Q4 (2021-12-31) | $34,919,000 | 12.46% | 3,145,887 | $9.70 |
| 18 | 2021 - Q3 (2021-09-30) | $29,005,000 | 15.66% | 3,145,887 | $10.88 |
| 19 | 2021 - Q2 (2021-06-30) | $35,391,000 | 16.31% | 3,145,887 | $11.53 |
| 20 | 2021 - Q1 (2021-03-31) | $30,651,000 | 15.27% | 2,905,300 | $11.24 |
| 21 | 2020 - Q4 (2020-12-31) | $31,306,000 | 15.82% | 2,885,300 | $10.33 |
| 22 | 2020 - Q3 (2020-09-30) | $27,948,000 | 17.39% | 2,875,300 | $9.52 |
| 23 | 2020 - Q2 (2020-06-30) | $22,887,000 | 16.86% | 2,875,300 | $10.32 |
| 24 | 2020 - Q1 (2020-03-31) | $24,943,000 | 23.65% | 2,870,300 | $10.41 |
| 25 | 2019 - Q4 (2019-12-31) | $32,463,000 | 21.66% | 2,870,300 | $10.64 |
| 26 | 2019 - Q3 (2019-09-30) | $31,200,000 | 16.6% | 2,870,300 | $10.89 |
| 27 | 2019 - Q2 (2019-06-30) | $26,192,000 | 13.42% | 2,795,300 | $10.09 |
| 28 | 2019 - Q1 (2019-03-31) | $33,590,000 | 15.95% | 2,735,300 | $12.21 |
| 29 | 2018 - Q4 (2018-12-31) | $31,759,000 | 16.1% | 2,682,400 | $13.73 |
| 30 | 2018 - Q3 (2018-09-30) | $38,627,000 | 16.11% | 2,682,400 | $13.83 |
| 31 | 2018 - Q2 (2018-06-30) | $39,968,000 | 14.75% | 2,682,400 | $13.90 |
| 32 | 2018 - Q1 (2018-03-31) | $35,005,000 | 12.17% | 2,682,400 | $13.14 |
| 33 | 2017 - Q4 (2017-12-31) | $33,798,000 | 11.66% | 2,682,400 | $12.64 |
| 34 | 2017 - Q3 (2017-09-30) | $34,737,000 | 12.42% | 2,682,400 | $13.18 |
| 35 | 2017 - Q2 (2017-06-30) | $39,833,000 | 13.28% | 2,682,400 | $13.92 |
| 36 | 2017 - Q1 (2017-03-31) | $32,188,000 | 11.79% | 2,682,400 | $12.66 |
| 37 | 2016 - Q4 (2016-12-31) | $37,016,000 | 13.33% | 2,682,400 | $13.85 |
| 38 | 2016 - Q3 (2016-09-30) | $35,970,000 | 12.03% | 2,682,400 | $12.11 |
| 39 | 2016 - Q2 (2016-06-30) | $28,863,000 | 10.44% | 2,682,400 | $11.03 |
| 40 | 2016 - Q1 (2016-03-31) | $28,165,000 | 11.06% | 2,682,400 | $10.98 |
| 41 | 2015 - Q4 (2015-12-31) | $31,732,000 | 10.72% | 2,682,400 | $12.28 |
| 42 | 2015 - Q3 (2015-09-30) | $31,101,000 | 12.45% | 2,665,000 | $13.25 |
| 43 | 2015 - Q2 (2015-06-30) | $38,239,000 | 14.72% | 2,650,000 | $14.43 |
| 44 | 2015 - Q1 (2015-03-31) | $36,967,000 | 16.33% | 2,650,000 | $13.82 |
| 45 | 2014 - Q4 (2014-12-31) | $36,596,000 | 15.51% | 2,650,000 | $12.92 |
| 46 | 2014 - Q3 (2014-09-30) | $30,039,000 | 13.89% | 2,630,000 | $12.48 |
| 47 | 2014 - Q2 (2014-06-30) | $21,412,000 | 9.86% | 1,714,400 | $11.77 |
| 48 | 2014 - Q1 (2014-03-31) | $19,132,000 | 9.34% | 1,714,400 | $10.97 |
| 49 | 2013 - Q4 (2013-12-31) | $19,141,000 | 8.57% | 1,637,986 | $11.94 |
| 50 | 2013 - Q3 (2013-09-30) | $19,156,000 | 7.22% | 1,637,986 | $13.95 |
| 51 | 2013 - Q2 (2013-06-30) | $22,853,000 | 8.58% | 1,802,801 | $13.83 |
| 52 | 2013 - Q1 (2013-03-31) | $27,344,000 | 9.31% | 1,964,700 | $11.79 |
| 53 | 2012 - Q4 (2012-12-31) | $19,781,000 | 6.87% | 2,172,260 | $10.05 |
| 54 | 2012 - Q3 (2012-09-30) | $24,057,000 | 8.77% | 2,193,271 | $9.37 |
| 55 | 2012 - Q1 (2012-03-31) | $16,005,000 | 5.59% | 2,568,271 | $6.31 |
| 56 | 2011 - Q4 (2011-12-31) | $14,156,000 | 5.48% | 2,564,524 | $5.63 |
| 57 | 2011 - Q3 (2011-09-30) | $12,665,000 | 5.37% | 2,497,924 | $6.06 |
| 58 | 2011 - Q2 (2011-06-30) | $12,930,000 | 4.75% | 2,012,714 | $6.05 |
| 59 | 2011 - Q1 (2011-03-31) | $10,055,000 | 4.84% | 1,587,500 | $6.30 |
| 60 | 2010 - Q4 (2010-12-31) | $7,365,000 | 3.61% | 1,247,218 | $6.21 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center